Four (4) each Genomic Sequencing Systems
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The Food and Drug Administration (FDA), under the Department of Health and Human Services, is seeking proposals for four (4) Illumina MiSeq i100 Plus or equal desktop genomic sequencing systems for its Human Foods Program (HFP). These systems will replace aging sequencers to support high-throughput, cost-effective, and rapid sequencing critical for food safety surveillance and regulatory compliance. This acquisition is not set-aside. Offers are due June 26, 2026, at 2 PM ET.
Scope of Work
This combined synopsis/solicitation requires the acquisition of four (4) genomic sequencing systems, or equal, that meet specific salient characteristics. Key requirements include:
- Equipment: Four (4) Illumina MiSeq i100 Plus or equivalent systems capable of whole genome sequencing for bacterial and viral organisms, with a benchtop size, embedded computer, support for various flow cell sizes (5M to 100M), read lengths between 2x150 bp and 2x500 bp, sequencing run time under 24 hours, and data output up to 30 GB per run. Systems must include reagent kits, a touchscreen monitor, integrated control software, and a hardware-accelerated DRAGEN Bio-IT secondary analysis pipeline or equal.
- Delivery & Installation: One unit each to be delivered and fully installed by certified manufacturer personnel at FDA facilities in College Park, MD; Laurel, MD; Bedford Park, IL; and Dauphin Island, AL.
- System Verification & Training: Conduct system validation and performance testing. Provide hands-on training for 5-8 FDA researchers per site on instrument operation, maintenance, software use, sample preparation, and data analysis.
- Warranty: A 12-month manufacturer warranty (parts and labor) is required.
Contract & Timeline
- Opportunity Type: Combined Synopsis/Solicitation (RFQ)
- Set-Aside: None
- NAICS Code: 334516 (Small Business Size Standard: 1,000 Employees)
- Period of Performance: Base period from contract award through warranty end date, with four (4) 12-month option periods for preventative maintenance, not to exceed five (5) years total.
- Questions Due: June 18, 2026, 10 AM ET
- Offers Due: June 26, 2026, 2 PM ET
- Published Date: June 15, 2026
Submission & Evaluation
- Submission Method: Email technical and price quotations, warranty terms, UEI and SAM.gov registration confirmation, lead time for delivery, and country of origin (if Buy American or Trade Agreements apply). Preferred file format is searchable PDF and Excel.
- Evaluation Criteria: Award will be made on a Lowest Price Technically Acceptable (LPTA) basis. Offers must meet all salient characteristics and minimum requirements to be considered technically acceptable.
- Offer Acceptance Period: 90 calendar days from the date specified for receipt of offers.
Additional Notes
All IT components must comply with HHS and FDA information security and privacy policies. Prior to award, all hardware and software must be submitted for approval by the FDA Chief Information Officer (CIO). Invoices must be submitted electronically through the U.S. Department of Treasury's Invoice Processing Platform (IPP).